Live
- TSMC praised as inspiration for doctors nationwide
- Lord Malayappa rides Pedda Sesha Vahanam
- Sri Lanka frees 50 Indian fishermen
- 2 Indian Americans named White House Fellows
- US, India sign MoU on critical minerals supply chain
- PM to release Rs 20,000 cr under PM-Kisan today
- ICMR, NTPC to promote solar energy in healthcare research
- IAF choppers yet to trace 2 foreign mountaineers stranded in Uttarakhand
- TG to unveil new sports policy soon
- KBR Park project gets govt nod
Just In
Antibodies in mild Coronavirus patients decline rapidly
In people with mild cases of COVID-19, antibodies against the novel coronavirus may drop sharply over the first three months after infection, according to a research which says the levels may decrease by roughly half every 73 days
California: In people with mild cases of COVID-19, antibodies against the novel coronavirus may drop sharply over the first three months after infection, according to a research which says the levels may decrease by roughly half every 73 days.
Scientists, including Javier Ibarrondo from the University of California Los Angeles (UCLA), noted that if the declining antibody levels sustained at that rate, they might disappear within about a year. Previous studies had suggested that antibodies which block the novel coronavirus are short-lived, but the rate at which they decrease has not been carefully defined.
According to the scientists, the current research, published in the New England Journal of Medicine, is the first to carefully estimate the disappearance rate of antibody proteins which are part of the body's humoral immunity.
"Our findings raise concern that humoral immunity against SARS-CoV-2 may not be long lasting in persons with mild illness, who compose the majority of persons with Covid-19," the scientists wrote in the research.
In the study, the researchers assessed 20 women and 14 men who recovered from mild cases of COVID-19.
They conducted antibody tests of the patients' blood samples drawn at an average of 36 days and 82 days after the initial symptoms of infection. The scientists said the findings raise concerns about the validity of antibody-based "immunity passports," which are documents that certify a person is immune to COVID-19.
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com